“Structural imprinting” of the cutaneous immune effector function

References

• Zihni C, Mills C, Matter K, Balda MS. Tight junctions: from simple barriers to multifunctional molecular gates. Nat Rev Mol Cell Biol. 2016;17:1–11. doi:10.1038/nrm.2016.80.
   PubMed Web of Science ®Google Scholar
• Gruber R, Börnchen C, Rose K, Daubmann A, Volksdorf T, Wladykowski E, Vidal-Y-Sy S, Peters EM, Danso M, Bouwstra JA, et al. Diverse regulation of claudin-1 and claudin-4 in atopic dermatitis. Am J Pathol. 2015;185:2777–2789. doi:10.1016/j.ajpath.2015.06.021.
   PubMed Web of Science ®Google Scholar
• Schmitz G, Muller G. Structure and function of lamellar bodies, lipid-protein complexes involved in storage and secretion of cellular lipids. J Lipid Res. 1991;32:1539–1570.
   PubMed Web of Science ®Google Scholar
• Nemes Z, Steinert PM. Bricks and mortar of the epidermal barrier. Exp Mol Med. 1999;31:5–19. doi:10.1038/emm.1999.2.
   PubMed Web of Science ®Google Scholar
• Rice RH, Green H. The cornified envelope of terminally differentiated human epidermal keratinocytes consists of cross-linked protein. Cell. 1977;11:417–422. doi:10.1016/0092-8674(77)90059-9.
   PubMed Web of Science ®Google Scholar
• Swartzendruber DC, Wertz PW, Madison KC, Downing DT. Evidence that the corneocyte has a chemically bound lipid envelope. J Invest Dermatol. 1987;88:709–713.
   PubMed Web of Science ®Google Scholar
• Sevilla LM, Nachat R, Groot KR, Klement JF, Uitto J, Djian P, Määttä A, Watt FM. Mice deficient in involucrin, envoplakin, and periplakin have a defective epidermal barrier. J Cell Biol. 2007;179:1599–1612. doi:10.1083/jcb.200706187.
   PubMed Web of Science ®Google Scholar
• Takeichi T, Akiyama M. Inherited ichthyosis: non-syndromic forms. J Dermatol. 2016;43:242–251. doi:10.1111/1346-8138.13243.
   PubMed Web of Science ®Google Scholar
• Kuramoto N, Takizawa T, Takizawa T, Matsuki M, Morioka H, Robinson JM, Yamanishi K. Development of ichthyosiform skin compensates for defective permeability barrier function in mice lacking transglutaminase 1. J Clin Invest. 2002;109:243–250. doi:10.1172/JCI0213563.
   PubMed Web of Science ®Google Scholar
• Ishitsuka Y, Ogawa T, Roop D. The KEAP1/NRF2 signaling pathway in keratinization. Antioxidants (Basel). 2020;9.
   Google Scholar
• Yamamoto M, Kensler TW, Motohashi H. The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis. Physiol Rev. 2018;98:1169–1203. doi:10.1152/physrev.00023.2017.
   PubMed Web of Science ®Google Scholar
• Schafer M, Farwanah H, Willrodt AH, Huebner AJ, Sandhoff K, Roop D, Hohl D, Bloch W, Werner S. Nrf2 links epidermal barrier function with antioxidant defense. EMBO Mol Med. 2012;4:364–379. doi:10.1002/emmm.201200219.
   PubMed Web of Science ®Google Scholar
• Wakabayashi N, Itoh K, Wakabayashi J, Motohashi H, Noda S, Takahashi S, Imakado S, Kotsuji T, Otsuka F, Roop DR, et al. Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. Nat Genet. 2003;35:238–245. doi:10.1038/ng1248.
   PubMed Web of Science ®Google Scholar
• Ogawa T, Ishitsuka Y, Nakamura Y, Kubota N, Saito A, Fujisawa Y, Watanabe R, Okiyama N, Suga Y, Roop DR, et al. NRF2 augments epidermal antioxidant defenses and promotes atopy. J Immunol. 2020;205(4):907–914. doi:10.4049/jimmunol.2000274.
   PubMed Web of Science ®Google Scholar
• Ogawa T, Ishitsuka Y, Inoue S, Nakamura Y, Saito A, Okiyama N, Fujisawa Y, Furuta J, Watanabe R, Fujimoto M, et al. Nuclear factor erythroid 2-related factor 2 (Nrf2) regulates epidermal keratinization under psoriatic skin inflammation. Am J Pathol. 2020;190(3):577–585. doi:10.1016/j.ajpath.2019.10.022.
   PubMed Web of Science ®Google Scholar
• Schafer M, Willrodt AH, Kurinna S, Link AS, Farwanah H, Geusau A, Gruber F, Sorg O, Huebner AJ, Roop DR, et al. Activation of Nrf2 in keratinocytes causes chloracne (MADISH)-like skin disease in mice. EMBO Mol Med. 2014;6(4):442–457. doi:10.1002/emmm.201303281.
   PubMed Web of Science ®Google Scholar
• Koch PJ, de Viragh PA, Scharer E, Bundman D, Longley MA, Bickenbach J, Kawachi Y, Suga Y, Zhou Z, Huber M, et al. Lessons from loricrin-deficient mice: compensatory mechanisms maintaining skin barrier function in the absence of a major cornified envelope protein. J Cell Biol. 2000;151(2):389–400. doi:10.1083/jcb.151.2.389.
   PubMed Web of Science ®Google Scholar
• Steinert PM. The complexity and redundancy of epithelial barrier function. J Cell Biol. 2000;151:F5–8. doi:10.1083/jcb.151.2.F5.
   PubMed Web of Science ®Google Scholar
• Ishitsuka Y, Huebner AJ, Rice RH, Koch PJ, Speransky VV, Steven AC, Roop DR. Lce1 family members are Nrf2-target genes that are induced to compensate for the loss of loricrin. J Invest Dermatol. 2016;136:1656–1663. doi:10.1016/j.jid.2016.04.022.
   PubMed Web of Science ®Google Scholar
• Huebner AJ, Dai D, Morasso M, Schmidt EE, Schafer M, Werner S, Roop DR. Amniotic fluid activates the nrf2/keap1 pathway to repair an epidermal barrier defect in utero. Dev Cell. 2012;23:1238–1246. doi:10.1016/j.devcel.2012.11.002.
   PubMed Web of Science ®Google Scholar
• Jarnik M, de Viragh PA, Scharer E, Bundman D, Simon MN, Roop DR, Steven AC. Quasi-normal cornified cell envelopes in loricrin knockout mice imply the existence of a loricrin backup system. J Invest Dermatol. 2002;118:102–109. doi:10.1046/j.0022-202x.2001.01661.x.
   PubMed Web of Science ®Google Scholar
• Ishitsuka Y, Roop DR. Loricrin confers photoprotective function against UVB in corneocytes. J Invest Dermatol. 2018;138(12):2684–2687. doi:10.1016/j.jid.2018.06.164.
   PubMed Web of Science ®Google Scholar
• Rice RH, Durbin-Johnson BP, Ishitsuka Y, Salemi M, Phinney BS, Rocke DM, Roop DR. Proteomic analysis of loricrin knockout mouse epidermis. J Proteome Res. 2016;15:2560–2566. doi:10.1021/acs.jproteome.6b00108.
   PubMed Web of Science ®Google Scholar
• Fukuyama K, Epstein WL. Sulfur-containing proteins and epidermal keratinization. J Cell Biol. 1969;40:830. doi:10.1083/jcb.40.3.830.
   PubMed Web of Science ®Google Scholar
• Van Scott E, Flesch P. Sulfhydryl and disulfide in keratinization. Science. 1954;119:70–71. doi:10.1126/science.119.3080.70.
   PubMed Web of Science ®Google Scholar
• Guttman-Yassky E, Suarez-Farinas M, Chiricozzi A, Nograles KE, Shemer A, Fuentes-Duculan J, Cardinale I, Lin P, Bergman R, Bowcock AM, et al. Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis. J Allergy Clin Immunol. 2009;124:1235–44 e58. doi:10.1016/j.jaci.2009.09.031.
   PubMed Web of Science ®Google Scholar
• Ong PY, Leung DY. Bacterial and viral infections in atopic dermatitis: a comprehensive review. Clin Rev Allergy Immunol. 2016;51:329–337. doi:10.1007/s12016-016-8548-5.
   PubMed Web of Science ®Google Scholar
• Ogawa T, Ishitsuka Y, Roop D, Fujimoto M. 314 Loricrin protects against chemical carcinogenesis but affects cancer immunoediting. J Invest Dermatol. 2019;139:S54. doi:10.1016/j.jid.2019.03.390.
   Web of Science ®Google Scholar
• Lack G. Update on risk factors for food allergy. J Allergy Clin Immunol. 2012;129:1187–1197. doi:10.1016/j.jaci.2012.02.036.
   PubMed Web of Science ®Google Scholar
• Dalziel K, Dykes PJ, Marks R. Inflammation due to intra-cutaneous implantation of stratum corneum. Br J Exp Pathol. 1984;65:107–115.
   PubMedGoogle Scholar
• Huber M, Rettler I, Bernasconi K, Frenk E, Lavrijsen SP, Ponec M, Bon A, Lautenschlager S, Schorderet D, Hohl D, et al. Mutations of keratinocyte transglutaminase in lamellar ichthyosis. Science. 1995;267:525–528. doi:10.1126/science.7824952.
   PubMed Web of Science ®Google Scholar
• Akiyama M, Sugiyama-Nakagiri Y, Sakai K, McMillan JR, Goto M, Arita K, Tsuji-Abe Y, Tabata N, Matsuoka K, Sasaki R, et al. Mutations in lipid transporter ABCA12 in harlequin ichthyosis and functional recovery by corrective gene transfer. J Clin Invest. 2005;115:1777–1784. doi:10.1172/JCI24834.
   PubMed Web of Science ®Google Scholar
• Zuo Y, Zhuang DZ, Han R, Isaac G, Tobin JJ, McKee M, Welti R, Brissette JL, Fitzgerald ML, Freeman MW, et al. ABCA12 maintains the epidermal lipid permeability barrier by facilitating formation of ceramide linoleic esters. J Biol Chem. 2008;283:36624–36635. doi:10.1074/jbc.M807377200.
   PubMed Web of Science ®Google Scholar
• Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, Goudie DR, Sandilands A, Campbell LE, Smith FJD, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet. 2006;38:441–446. doi:10.1038/ng1767.
   PubMed Web of Science ®Google Scholar
• Harding CR, Aho S, Bosko CA. Filaggrin - revisited. Int J Cosmet Sci. 2013;35:412–423. doi:10.1111/ics.12049.
   PubMed Web of Science ®Google Scholar
• Presland RB, Boggess D, Lewis SP, Hull C, Fleckman P, Sundberg JP. Loss of normal profilaggrin and filaggrin in flaky tail (ft/ft) mice: an animal model for the filaggrin-deficient skin disease ichthyosis vulgaris. J Invest Dermatol. 2000;115:1072–1081.
   PubMed Web of Science ®Google Scholar
• Saunders SP, Goh CS, Brown SJ, Palmer CN, Porter RM, Cole C, Campbell LE, Gierlinski M, Barton GJ, Schneider G, et al. Tmem79/Matt is the matted mouse gene and is a predisposing gene for atopic dermatitis in human subjects. J Allergy Clin Immunol. 2013;132:1121–1129. doi:10.1016/j.jaci.2013.08.046.
   PubMed Web of Science ®Google Scholar
• Sasaki T, Shiohama A, Kubo A, Kawasaki H, Ishida-Yamamoto A, Yamada T, Hachiya T, Shimizu A, Okano H, Kudoh J, et al. A homozygous nonsense mutation in the gene for Tmem79, a component for the lamellar granule secretory system, produces spontaneous eczema in an experimental model of atopic dermatitis. J Allergy Clin Immunol. 2013;132:1111–20 e4. doi:10.1016/j.jaci.2013.08.027.
   PubMed Web of Science ®Google Scholar
• Dawkins R. The selfish gene. Oxford, England: Oxford university press; 2016.
   Google Scholar
• Grall A, Guaguere E, Planchais S, Grond S, Bourrat E, Hausser I, Hitte C, Le Gallo M, Derbois C, Kim G-J, et al. PNPLA1 mutations cause autosomal recessive congenital ichthyosis in golden retriever dogs and humans. Nat Genet. 2012;44:140–147. doi:10.1038/ng.1056.
   PubMed Web of Science ®Google Scholar
• Israeli S, Khamaysi Z, Fuchs-Telem D, Nousbeck J, Bergman R, Sarig O, Sprecher E. A mutation in LIPN, encoding epidermal lipase N, causes a late-onset form of autosomal-recessive congenital ichthyosis. Am J Hum Genet. 2011;88:482–487. doi:10.1016/j.ajhg.2011.02.011.
   PubMed Web of Science ®Google Scholar
• Jobard F, Lefevre C, Karaduman A, Blanchet-Bardon C, Emre S, Weissenbach J, Özgüc M, Lathrop M, Prud’homme J-F, Fischer J. Lipoxygenase-3 (ALOXE3) and 12(R)-lipoxygenase (ALOX12B) are mutated in non-bullous congenital ichthyosiform erythroderma (NCIE) linked to chromosome 17p13.1. Hum Mol Genet. 2002;11:107–113. doi:10.1093/hmg/11.1.107.
   PubMed Web of Science ®Google Scholar
• Lefevre C, Audebert S, Jobard F, Bouadjar B, Lakhdar H, Boughdene-Stambouli O, Blanchet-Bardon C, Heilig R, Foglio M, Weissenbach J, et al. Mutations in the transporter ABCA12 are associated with lamellar ichthyosis type 2. Hum Mol Genet. 2003;12:2369–2378. doi:10.1093/hmg/ddg235.
   PubMed Web of Science ®Google Scholar
• Ohno Y, Nakamichi S, Ohkuni A, Kamiyama N, Naoe A, Tsujimura H, Yokose U, Sugiura K, Ishikawa J, Akiyama M, et al. Essential role of the cytochrome P450 CYP4F22 in the production of acylceramide, the key lipid for skin permeability barrier formation. Proc Natl Acad Sci U S A. 2015;112:7707–7712.
   PubMed Web of Science ®Google Scholar
• Radner FP, Marrakchi S, Kirchmeier P, Kim GJ, Ribierre F, Kamoun B, Abid L, Leipoldt M, Turki H, Schempp W, et al. Mutations in CERS3 cause autosomal recessive congenital ichthyosis in humans. PLoS Genet. 2013;9:e1003536. doi:10.1371/journal.pgen.1003536.
   PubMed Web of Science ®Google Scholar
• Takeichi T, Hirabayashi T, Miyasaka Y, Kawamoto A, Okuno Y, Taguchi S, Tanahashi K, Murase C, Takama H, Tanaka K, et al. SDR9C7 catalyzes critical dehydrogenation of acylceramides for skin barrier formation. J Clin Invest. 2020;130:890–903. doi:10.1172/JCI130675.
   PubMed Web of Science ®Google Scholar
• Wajid M, Kurban M, Shimomura Y, Christiano AM. NIPAL4/ichthyin is expressed in the granular layer of human epidermis and mutated in two Pakistani families with autosomal recessive ichthyosis. Dermatology. 2010;220:8–14. doi:10.1159/000265757.
   PubMed Web of Science ®Google Scholar
• Heinz L, Kim GJ, Marrakchi S, Christiansen J, Turki H, Rauschendorf MA, Lathrop M, Hausser I, Zimmer AD, Fischer J, et al. Mutations in SULT2B1 cause autosomal-recessive congenital ichthyosis in humans. Am J Hum Genet. 2017;100:926–939. doi:10.1016/j.ajhg.2017.05.007.
   PubMed Web of Science ®Google Scholar
• Kirchmeier P, Zimmer A, Bouadjar B, Rosler B, Fischer J. Whole-exome-sequencing reveals small deletions in CASP14 in patients with autosomal recessive inherited ichthyosis. Acta Derm Venereol. 2017;97:102–104. doi:10.2340/00015555-2510.
   PubMed Web of Science ®Google Scholar
• Basel-Vanagaite L, Attia R, Ishida-Yamamoto A, Rainshtein L, Amitai DB, Lurie R, Pasmanik-Chor M, Indelman M, Zvulunov A, Saban S, et al. Autosomal recessive ichthyosis with hypotrichosis caused by a mutation in ST14, encoding type II transmembrane serine protease matriptase. Am J Human Genet. 2007;80:467–477. doi:10.1086/512487.
   PubMed Web of Science ®Google Scholar
• Mehrel T, Hohl D, Rothnagel JA, Longley MA, Bundman D, Cheng C, Lichti U, Bisher ME, Steven AC, Steinert PM, et al. Identification of a major keratinocyte cell envelope protein, loricrin. Cell. 1990;61:1103–1112. doi:10.1016/0092-8674(90)90073-N.
   PubMed Web of Science ®Google Scholar
• Redondo P, Bauza A. Topical N-acetylcysteine for lamellar ichthyosis. Lancet. 1999;354:1880. doi:10.1016/S0140-6736(99)04245-2.
   PubMed Web of Science ®Google Scholar
• Suzuki T, Motohashi H, Yamamoto M. Toward clinical application of the Keap1-Nrf2 pathway. Trends Pharmacol Sci. 2013;34:340–346.
   PubMed Web of Science ®Google Scholar
• Rice RH, Green H. Presence in human epidermal cells of a soluble protein precursor of the cross-linked envelope: activation of the cross-linking by calcium ions. Cell. 1979;18:681–694.
   PubMed Web of Science ®Google Scholar
• Ishitsuka Y, Roop DR. Loricrin confers photoprotective function against UVB in corneocytes. J Invest Dermatol. 2018;138:2684–2687
   PubMed Web of Science ®Google Scholar
• Vermeij WP, Alia A, Backendorf C. ROS quenching potential of the epidermal cornified cell envelope. J Invest Dermatol. 2011;131:1435–1441. doi:10.1038/jid.2010.433.
   PubMed Web of Science ®Google Scholar
• Gibbs S, Fijneman R, Wiegant J, van Kessel AG, van De Putte P, Backendorf C. Molecular characterization and evolution of the SPRR family of keratinocyte differentiation markers encoding small proline-rich proteins. Genomics. 1993;16:630–637. doi:10.1006/geno.1993.1240.
   PubMed Web of Science ®Google Scholar
• Jackson B, Tilli CM, Hardman MJ, Avilion AA, MacLeod MC, Ashcroft GS, Byrne C. Late cornified envelope family in differentiating epithelia--response to calcium and ultraviolet irradiation. J Invest Dermatol. 2005;124:1062–1070. doi:10.1111/j.0022-202X.2005.23699.x.
   PubMed Web of Science ®Google Scholar
• de Cid R, Riveira-Munoz E, Zeeuwen PL, Robarge J, Liao W, Dannhauser EN, Giardina E, Stuart PE, Nair R, Helms C, et al. Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis. Nat Genet. 2009;41:211–215. doi:10.1038/ng.313.
   PubMed Web of Science ®Google Scholar
• Prestera T, Zhang Y, Spencer SR, Wilczak CA, Talalay P. The electrophile counterattack response: protection against neoplasia and toxicity. Adv Enzyme Regul. 1993;33:281–296. doi:10.1016/0065-2571(93)90024-8.
   PubMedGoogle Scholar
• Kehren J, Desvignes C, Krasteva M, Ducluzeau MT, Assossou O, Horand F, Hahne M, Kägi D, Kaiserlian D, Nicolas J-F. Cytotoxicity is mandatory for CD8(+) T cell-mediated contact hypersensitivity. J Exp Med. 1999;189:779–786. doi:10.1084/jem.189.5.779.
   PubMed Web of Science ®Google Scholar
• Modi BG, Neustadter J, Binda E, Lewis J, Filler RB, Roberts SJ, Kwong BY, Reddy S, Overton JD, Galan A, et al. Langerhans cells facilitate epithelial DNA damage and squamous cell carcinoma. Science. 2012;335:104–108. doi:10.1126/science.1211600.
   PubMed Web of Science ®Google Scholar
• Kaplan DH, Igyarto BZ, Gaspari AA. Early immune events in the induction of allergic contact dermatitis. Nat Rev Immunol. 2012;12:114–124. doi:10.1038/nri3150.
   PubMed Web of Science ®Google Scholar
• Engelbrecht TN, Schroeter A, Hauss T, Neubert RH. Lipophilic penetration enhancers and their impact to the bilayer structure of stratum corneum lipid model membranes: neutron diffraction studies based on the example oleic acid. Biochim Biophys Acta. 2011;1808:2798–2806. doi:10.1016/j.bbamem.2011.08.012.
   PubMed Web of Science ®Google Scholar
• Steinbrink K, Sorg C, Macher E. Low zone tolerance to contact allergens in mice: a functional role for CD8+ T helper type 2 cells. J Exp Med. 1996;183:759–768. doi:10.1084/jem.183.3.759.
   PubMed Web of Science ®Google Scholar
• Matzinger P, Kamala T. Tissue-based class control: the other side of tolerance. Nat Rev Immunol. 2011;11:221–230. doi:10.1038/nri2940.
   PubMed Web of Science ®Google Scholar
• Sarantopoulos S, Cardones AR, Sullivan KM. How I treat refractory chronic graft-versus-host disease. Blood. 2019;133:1191–1200. doi:10.1182/blood-2018-04-785899.
   PubMed Web of Science ®Google Scholar
• Migden MR, Khushalani NI, Chang ALS, Lewis KD, Schmults CD, Hernandez-Aya L, Meier F, Schadendorf D, Guminski A,  Hauschild A,  Wong DJ, et al. Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial. Lancet Oncol. 2020;21:294–305.
   PubMed Web of Science ®Google Scholar
• Kojima T, Hara H, Yamaguchi K, Hironaka S, Iwasa S, Kato K, Tsushima T, Yasui H, Ura T, Muro K, et al. Phase II study of nivolumab (ONO-4538/BMS-936558) in patients with esophageal cancer: preliminary report of overall survival. J Clin Oncol. 2016;34:TPS175–TPS. doi:10.1200/jco.2016.34.4_suppl.tps175.
   Google Scholar
• Santin A, Deng W, Frumovitz MM, Huh WK, Khleif S, Lankes HA, Ratner E, O’Cearbhaill R, Jazaeri AA, Birrer M, et al. A phase II evaluation of nivolumab, a fully human antibody against PD-1, in the treatment of persistent or recurrent cervical cancer. J Clin Oncol. 2018;36:5536. doi:10.1200/JCO.2018.36.15_suppl.5536.
   Web of Science ®Google Scholar
• Amouzegar A, Chauhan SK, Dana R. Alloimmunity and tolerance in corneal transplantation. J Immunol. 2016;196:3983–3991. doi:10.4049/jimmunol.1600251.
   PubMed Web of Science ®Google Scholar
• Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science. 1995;270:1189–1192.
   PubMed Web of Science ®Google Scholar
• Worbs T, Hammerschmidt SI, Forster R. Dendritic cell migration in health and disease. Nat Rev Immunol. 2017;17:30–48.
   PubMed Web of Science ®Google Scholar
• Ohnmacht C, Pullner A, King SB, Drexler I, Meier S, Brocker T, Voehringer D. Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity. J Exp Med. 2009;206:549–559.
   PubMed Web of Science ®Google Scholar
• Birnberg T, Bar-On L, Sapoznikov A, Caton ML, Cervantes-Barragan L, Makia D, Krauthgamer R, Brenner O, Ludewig B, Brockschnieder D, et al. Lack of conventional dendritic cells is compatible with normal development and T cell homeostasis, but causes myeloid proliferative syndrome. Immunity. 2008;29:986–997. doi:10.1016/j.immuni.2008.10.012.
   PubMed Web of Science ®Google Scholar
• Doebel T, Voisin B, Nagao K. Langerhans cells - the macrophage in dendritic cell clothing. Trends Immunol. 2017;38:817–828. doi:10.1016/j.it.2017.06.008.
   PubMed Web of Science ®Google Scholar
• Hovav AH. Mucosal and skin langerhans cells - nurture calls. Trends Immunol. 2018;39:788–800. doi:10.1016/j.it.2018.08.007.
   PubMed Web of Science ®Google Scholar
• Streilein JW, Toews GB, Bergstresser PR. Corneal allografts fail to express Ia antigens. Nature. 1979;282:326–327.
   PubMed Web of Science ®Google Scholar
• Hattori T, Chauhan SK, Lee H, Ueno H, Dana R, Kaplan DH, Saban DR. Characterization of Langerin-expressing dendritic cell subsets in the normal cornea. Invest Ophthalmol Vis Sci. 2011;52:4598–4604. doi:10.1167/iovs.10-6741.
   PubMed Web of Science ®Google Scholar
• Chang SY, Cha HR, Chang JH, Ko HJ, Yang H, Malissen B, Iwata M, Kweon M. Lack of retinoic acid leads to increased langerin-expressing dendritic cells in gut-associated lymphoid tissues. Gastroenterology. 2010;138:1468–78,78 e1-6. doi:10.1053/j.gastro.2009.11.006.
   Web of Science ®Google Scholar
• de Witte L, Nabatov A, Pion M, Fluitsma D, de Jong MA, de Gruijl T, Piguet V, Kooyk YV, Geijtenbeek TBH. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nat Med. 2007;13:367–371. doi:10.1038/nm1541.
   PubMed Web of Science ®Google Scholar
• Dupont C, Kalach N, Soulaines P, Legoue-Morillon S, Piloquet H, Benhamou PH. Cow’s milk epicutaneous immunotherapy in children: a pilot trial of safety, acceptability, and impact on allergic reactivity. J Allergy Clin Immunol. 2010;125:1165–1167.
   PubMed Web of Science ®Google Scholar
• Iwasaki A, Medzhitov R. Control of adaptive immunity by the innate immune system. Nat Immunol. 2015;16:343–353. doi:10.1038/ni.3123.
   PubMed Web of Science ®Google Scholar
• Sigmundsdottir H, Butcher EC. Environmental cues, dendritic cells and the programming of tissue-selective lymphocyte trafficking. Nat Immunol. 2008;9:981–987.
   PubMed Web of Science ®Google Scholar
• Imakado S, Bickenbach JR, Bundman DS, Rothnagel JA, Attar PS, Wang XJ, Walczak VR, Wisniewski S, Pote J, Gordon JS, et al. Targeting expression of a dominant-negative retinoic acid receptor mutant in the epidermis of transgenic mice results in loss of barrier function. Genes Dev. 1995;9:317–329. doi:10.1101/gad.9.3.317.
   PubMed Web of Science ®Google Scholar
• Attar PS, Wertz PW, McArthur M, Imakado S, Bickenbach JR, Roop DR. Inhibition of retinoid signaling in transgenic mice alters lipid processing and disrupts epidermal barrier function. Mol Endocrinol. 1997;11:792–800. doi:10.1210/mend.11.6.0010.
   PubMedGoogle Scholar
• Xie Z, Komuves L, Yu QC, Elalieh H, Ng DC, Leary C, Chang S, Crumrine D, Bikle DD, Yoshizawa T, et al. Lack of the vitamin D receptor is associated with reduced epidermal differentiation and hair follicle growth. J Invest Dermatol. 2002;118:11–16. doi:10.1046/j.1523-1747.2002.01644.x.
   PubMed Web of Science ®Google Scholar
• Li M, Hener P, Zhang Z, Kato S, Metzger D, Chambon P. Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis. Proc Natl Acad Sci U S A. 2006;103:11736–11741. doi:10.1073/pnas.0604575103.
   PubMed Web of Science ®Google Scholar
• Li M, Messaddeq N, Teletin M, Pasquali JL, Metzger D, Chambon P. Retinoid X receptor ablation in adult mouse keratinocytes generates an atopic dermatitis triggered by thymic stromal lymphopoietin. Proc Natl Acad Sci U S A. 2005;102:14795–14800. doi:10.1073/pnas.0507385102.
   PubMed Web of Science ®Google Scholar
• Ruzicka T, Larsen FG, Galewicz D, Horvath A, Coenraads PJ, Thestrup-Pedersen K, Ortonne JP, Zouboulis CC, Harsch M, Brown TC, et al. Oral alitretinoin (9-cis-retinoic acid) therapy for chronic hand dermatitis in patients refractory to standard therapy: results of a randomized, double-blind, placebo-controlled, multicenter trial. Arch Dermatol. 2004;140:1453–1459.
   PubMed Web of Science ®Google Scholar
• Digiovanna JJ, Mauro T, Milstone LM, Schmuth M, Toro JR. Systemic retinoids in the management of ichthyoses and related skin types. Dermatol Ther. 2013;26:26–38.
   PubMed Web of Science ®Google Scholar
• Agace WW, Persson EK. How vitamin A metabolizing dendritic cells are generated in the gut mucosa. Trends Immunol. 2012;33:42–48. doi:10.1016/j.it.2011.10.001.
   PubMed Web of Science ®Google Scholar
• Iwata M, Hirakiyama A, Eshima Y, Kagechika H, Kato C, Song SY. Retinoic acid imprints gut-homing specificity on T cells. Immunity. 2004;21:527–538. doi:10.1016/j.immuni.2004.08.011.
   PubMed Web of Science ®Google Scholar
• Kumar S, Sandell LL, Trainor PA, Koentgen F, Duester G. Alcohol and aldehyde dehydrogenases: retinoid metabolic effects in mouse knockout models. Biochim Biophys Acta. 2012;1821:198–205.
   PubMed Web of Science ®Google Scholar
• Clugston RD, Blaner WS. The adverse effects of alcohol on vitamin A metabolism. Nutrients. 2012;4:356–371. doi:10.3390/nu4050356.
   PubMed Web of Science ®Google Scholar
• Jackson SF, Fell HB. Epidermal fine structure in embryonic chicken skin during atypical differentiation induced by vitamin A in culture. Dev Biol. 1963;7:394–419. doi:10.1016/0012-1606(63)90132-5.
   Web of Science ®Google Scholar
• Hosokawa S, Shinzato M, Kaneko C, Shamoto M. Migration and maturation of Langerhans cells in squamous metaplasia of the rat trachea induced by vitamin A deficiency. Virchows Arch B Cell Pathol Incl Mol Pathol. 1993;63:159–166. doi:10.1007/BF02899256.
   PubMedGoogle Scholar
• Chorro L, Sarde A, Li M, Woollard KJ, Chambon P, Malissen B, Kissenpfennig A, Barbaroux J-B, Groves R, Geissmann F. Langerhans cell (LC) proliferation mediates neonatal development, homeostasis, and inflammation-associated expansion of the epidermal LC network. J Exp Med. 2009;206:3089–3100.
   PubMed Web of Science ®Google Scholar
• Koenig U, Amatschek S, Mildner M, Eckhart L, Tschachler E. Aldehyde dehydrogenase 1A3 is transcriptionally activated by all-trans-retinoic acid in human epidermal keratinocytes. Biochem Biophys Res Commun. 2010;400:207–211. doi:10.1016/j.bbrc.2010.08.035.
   PubMed Web of Science ®Google Scholar
• Madison KC. Barrier function of the skin: “la raison d’etre” of the epidermis. J Invest Dermatol. 2003;121:231–241. doi:10.1046/j.1523-1747.2003.12359.x.
   PubMed Web of Science ®Google Scholar